Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells

Journal of Cellular Physiology

Volumn 220, Issue 1, 2009, Pages 35-44

  Salvatori, Luisa ^a,b,c   Caporuscio, Francesca ^a,c   Coroniti, Giuseppe ^b   Starace, Giuseppe ^b,c   Frati, Luigi ^a,d   Russo, Matteo Antonio ^a,e   Petrangeli, Elisa ^a,b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d IRCCS NEUROMED   (Italy)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTISENSE OLIGONUCLEOTIDE; DAIDZEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; 4-HYDROXYTAMOXIFEN; BIOLOGICAL MARKER; DRUG DERIVATIVE; EGFR PROTEIN, HUMAN; ISOFLAVONE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

APOPTOSIS; ARTICLE; BONE REMODELING; CELL COUNT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA CONTENT; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROSCOPY; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL CYCLE; CELL SHAPE; DRUG EFFECT; GENETICS; METABOLISM; OSTEOSARCOMA; PATHOLOGY; TIME; TUMOR CELL LINE;

APOPTOSIS; BIOLOGICAL MARKERS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; ISOFLAVONES; OSTEOBLASTS; OSTEOSARCOMA; PHYTOESTROGENS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TIME FACTORS;

EID: 65549102006     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21724     Document Type: Article

References (42)

1. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP. 1997. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070.
2. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Shlomai Z, Kleinberger-Doron N, Gazit A, Plowman G, Levitzki R, Tsvieli R, Levitzki A. 1997. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes. Cancer Res 57:3741-3750.
3. Bodine PV, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB, Komm BS. 1998. Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 139:2048-2057.
4. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
5. Chan SY, Wong RWC. 2000. Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275:38693-38698.
6. Chien HH, Lin WL, Cho MI. 2000. Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor. Calcif Tissue Int 67:141-150.
7. Cosman F, Lindsay R. 1999. Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418-434.
8. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA. 1997. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82:4258-4265.
9. Franz-Odendaal TA, Hall BK, Witten PE. 2006. Buried alive: how osteoblasts become osteocytes. Dev Dyn 235:176-190.
10. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139.
11. Jordan VC, Gapstur S, Morrow M. 2001. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Nat Cancer Inst 93:1449-1457.
12. Kanno S, Hirano S, Kayama F. 2004. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 196:137-145.
13. Kari C, Chan TO, Rocha de Quadros M, Rodeck U. 2003. Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage. Cancer Res 63:1-5.
14. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC. 2004. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β. Mol Biol Cell 15:1262-1272.
15. Knothe Tate ML, Adamson JR, Tami AE, Bauer TW. 2004. The osteocyte. Int J Biochem Cell Biol 36:1-8.
16. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263.
17. Kurzer MS, Xu X. 1997. Dietary phytoestrogens. Annu Rev Nutr 17:353-381.
18. Lima F, Vico L, Lafage-Proust MH, van der Saag P, Alexandre C, Thomas T. 2004. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type. Bone 35:1127-1135.
19. Manolagas SC. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137.
20. Manolagas SC, Kousteni S, Jilka RL. 2002. Sex steroids and bone. Recent Prog Horm Res 57:385-409.
21. Matsuda N, Yokoyama K, Takeshita S, Watanabe M. 1998. Role of epidermal growth factor and its receptor in mechanical stress-induced differentiation of human periodontal ligament cells in vitro. Arch Oral Biol 43:987-997.
22. McDonnell DP, Norris JD. 2002. Connections and regulation of the human estrogen receptor. Science 296:1642-1644.
23. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS. 1998. Transcription activation by the human estrogen receptor subtype beta (ER beta) studiedwith ER beta and ER alpha receptor chimeras. Endocrinology 139:4513-4522.
24. Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC. 2003. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ. J Cell Biochem 90:315-326.
25. Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Kosla S, Spelsberg TC. 2005. Estrogen receptor α and β heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol Endocrinol 19:1555-1568.
26. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. 2002. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912.
27. Mosselman S, Polman J, Dijkema R. 1996. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53.
28. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. 1997. Expression of estrogen receptor β in rat bone. Endocrinology 138:4509-4512.
29. Peng D, Fan Z, Lu Y, DeBlasio T, Scher H, Mendelsohn J. 1996. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res 56:3666-3669.
30. Petch AK, Sohail M, Hughes MD, Benter I, Darling J, Southern EM, Akhtar S. 2003. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Biochem Pharmacol 66:819-830.
31. Riggs BL, Khosla S, Melton LJ III. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
32. Roudsari AH, Tahbaz F, Hossein-Nezhad A, Arjmandi B, Larijani B, Kimiagar SM. 2005. Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial. Nutr J 4:30-34.
33. Rudnik V, Sanyal A, Syed FA, Monroe DG, Spelsberg TC, Oursler MJ, Kosla S. 2008. Loss of ERE binding activity by estrogen receptor-α alters basal and estrogen-stimulated bone-related gene expression by osteoblastic cells. J Cell Biochem 103:896-907.
34. Salvatori L, Pallante P, Ravenna L, Chinzari P, Frati L, Russo MA, Petrangeli E. 2003. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ERα and β subtypes via an Sp1 site. Oncogene 22:4875-4881.
35. Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E. 2000. Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology 141:2266-2274.
36. Seth D, Shaw K, Jazayeri J, Leedman PJ. 1999. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-α in human prostate cancer cells. Br J Cancer 80:657-669.
37. Shang Y, Brown M. 2002. Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468.
38. Simon AM, Manigrasso MB, O'Connor JP. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17:963-976.
39. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. 1999. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819-828.
40. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. 2004. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ERβ in human osteosarcoma cells: distinct and common target genes for these receprors. Endocrinology 145:3473-3486.
41. Woodworth CD, Michael E, Marker D, Allen S, Smith L, Nees M. 2005. Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol Cancer Ther 4:650-658.
42. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.